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There is an increasing number of older patients with cancer
as a logical consequence of a longer life span which pro-
motes prolonged exposure to carcinogens and accumula-
tion of genetic alterations. In addition, the Western world is
currently facing an unprecedented demographic change
resulting in ageing populations (Repetto & Balducci 2002).
Practitioners and health-care professionals are faced with
the difficult task to manage these older cancer patients in
their routine clinical practices, and to select the proper
tailored treatment and care. Difficulties arise as they have
to answer challenging questions such as: Will the cancer
treatment do more harm than good when considering
quality of life? Will they be able to tolerate their treatment
at full doses or will dose reductions be necessary? Will the
patient die due to their cancer diagnosis or due to a co-
existing morbidity? Is a treatment with curative intent
possible or do we need to opt for supportive care?
(Monfardini & Balducci 1999; Balducci 2000)
These questions illustrate the heterogeneity of older
patients – and they are a group in which chronological and
functional age may not correspond. The spectrum of
impairment can range from those who are independent, to
those who are at moderate risk of health deterioration, and
those who are at a high risk of functional decline or mor-
tality (Mohile et al. 2007). Therefore, proper selection of
patients is the key to administering a safe and effective
cancer treatment (Hurria et al. 2014).
The history of modern evidence-based ‘geriatric oncol-
ogy’ dates back to the time around 1990 when geriatri-
cians developed and validated a holistic approach to
assess older patients (Reuben et al. 1999). Their compre-
hensive geriatric assessment (CGA) is a multidisciplinary,
in-depth evaluation to assess life expectancy and the risk
of morbidity and mortality (Extermann & Hurria 2007;
Hurria et al. 2014). Its benefits include amelioration of
subjects’ well-being, prevention of geriatric syndromes or
institutionalisation, and prolongation of life (Rubenstein
et al. 1984; Stuck et al. 1993; Tinetti et al. 1994; Cohen
et al. 2002).
The first attempt to adapt the CGA for use in an oncol-
ogy setting was made by Monfardini et al. (1996). The
efficacy of their tool was later prospectively evaluated in a
large sample of older cancer patients by the Italian Group
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of Geriatric Oncology from 1995 to 1998 (Repetto &
Balducci 2002; Repetto et al. 2002). Around the beginning
of the new century, clinical studies validated the impor-
tance of the use of a CGA in routine oncology practice
(Monfardini & Balducci 1999; Extermann & Hurria 2007).
A trial including 660 women diagnosed with primary
breast cancer showed that the domains included within a
CGA are associated with poor treatment tolerance and
predict mortality at 7 years of follow-up (Clough-Gorr
et al. 2010). Another landmark study in elderly patients
with ovarian cancer illustrated that functional depend-
ence, as assessed with a CGA, is associated with a risk of
chemotherapy toxicity (Freyer et al. 2005). Decoster et al.
(2013) showed that CGA influences oncological treatment
decisions and may trigger the use of less aggressive as well
as more aggressive treatments (Decoster et al. 2013).
Moreover, a trial conducted in head and neck cancer
patients illustrated that a CGA provides an indication of
the health-related quality of life (QoL). With this informa-
tion, physicians could tailor care and thus improve
patients’ QoL (Pottel et al. 2014).
Through efforts made during the last decade, tremen-
dous progress has been made towards the optimisation of
comprehensive geriatric assessments in routine multidis-
ciplinary cancer care (Pottel et al. 2014; Sattar et al. 2014).
Researchers have also conducted trials on the most
optimal screening tool to detect those patients in need of
a CGA (Kenis et al. 2013; Soubeyran et al. 2014). Others
have proposed and validated new measures for use within
the assessment (Ketelaars et al. 2013; Lycke et al. 2014).
As a result, a CGA has been endorsed as the key treatment
approach in older cancer patients, by several international
expert panels. These include: the National Comprehen-
sive Cancer Network, the European Organisation for
Research and Treatment of Cancer, and the Society of
Geriatric Oncology (Pallis et al. 2010; Decoster et al.
2014; Hurria et al. 2014; Wildiers et al. 2014). Current
senior adult oncology care guidelines can be consulted on
their respective websites (http://www.nccn.org; http://
www.eortc.org; http://www.siog.org). Despite the growing
evidence, there remains high variability among countries
and centres in the application of the guidelines, mainly
because of shortage of staff and other economic and insti-
tutional constraints (Jonker et al. 2014). Several special-
ised ‘geriatric oncology’ units are being established, but
since cancer is a disease of older people, we believe that a
geriatric evaluation and geriatric interventions should
become available to all older individuals affected by
cancer.
Looking beyond oncology settings, elderly patients with
cancer need community-based care which complements
their specialist treatments. Primary care features, to a
growing extent, in new models of cancer treatment and
survivorship, and there is evidence of increasing involve-
ment with elderly cancer patients (Bowman et al. 2010).
Accordingly, there are widespread calls for the care of
elderly patients with cancer to be better integrated
between primary and secondary care (Buntinx et al. 2014);
these patients will typically have multiple comorbidities
requiring both generalist and specialist approaches. With
this ‘Ageing and Cancer’ themed issue, the European
Journal of Cancer Care wants to support researchers who
aim to move geriatric oncology forward (Debruyne et al.
2014). It is therefore our pleasure to present several inter-
esting studies that look into a range of research questions
from different angles. O’Donovan et al. (2015) introduce
new expert consensus panel guidelines on geriatric assess-
ments in oncology. As a result of their Delphi study,
the expert panel recommends criteria that should be
included when introducing CGAs in a clinical geriatric
oncology programme in Ireland. Their findings should be
transferrable to many other countries and health systems
(O’Donovan et al. 2015). Chau et al. (2015) and Qiu et al.
(2015) both conducted traditional clinical trials comparing
younger and older patients. The latter study looks at dif-
ferences in clinicopathological features and prognosis of
triple-negative breast cancer (TNBC) between younger
(<60 years old) and elderly (≥60 years old) patients. They
emphasise that physicians need to be careful when choos-
ing adjuvant treatments for older patients with TNBC.
The retrospective nature of their study and the definition
of TNBC is a limitation of the study, and there is defi-
nitely a need for more research (funding) in this area in the
future so that prospective trials are possible in older
patients (Qiu et al. 2015). Chau et al. (2015) address clini-
cal outcomes following neoadjuvant cisplatin-based
chemotherapy for bladder cancer in both subgroups. They
suggest that older patients receiving neo-adjuvant chemo-
therapy followed by cystectomy or radiotherapy can
show similar clinical outcomes as younger patients if they
present with a good functional ability and limited
comorbidities (Chau et al. 2015). A major caveat in this
and many other studies is that a CGA was not included
and that the population under study may not be applicable
to other (more vulnerable) older patient populations.
Indeed, implementation of CGA in daily practice will not
only benefit patients directly, but also indirectly since one
can anticipate a better quality of future prospective and
retrospective clinical research. Even in the case where the
implementation of a CGA in daily practice is not possible
due to economic reasons, we do would strongly advocate
to implement a minimal assessment under the form of a
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G8 score. This simple and reliable (screening) instrument
has on its own the capacity to identify vulnerable patients
and has a strong prognostic value for functional decline
and overall survival (Kenis et al. 2013). The study of
Hamama-Raz et al. (2015) aimed at exploring whether
patients’ QoL and functional dependence could have a
reciprocal effect on each other over time. Interestingly,
it showed that an assessment of QoL can predict func-
tional decline in older cancer patients receiving treatment
(Hamama-Raz et al. 2015). Lastly, Bol et al. (2015)
addressed website satisfaction and recall of online cancer
information in older colorectal cancer patients and indi-
cate that there is also great potential for e-health in this
patient population (Bol et al. 2015).
In conclusion, we argue that the time to integrate geri-
atric oncology into our daily practices has arrived. It is
another paradigm of multidisciplinary cancer care that
will gain further importance in the near future.
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